SPML Infra Ltd – a Multi-sector Infrastructure Player: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 18, 2025, 10:13 pm

Quick Insight

SPML Infra Ltd, a multi-sector infrastructure player in the construction and contracting industry, currently boasts a share price of 284 with a market capitalization of 2,042 Cr. The company's P/E ratio stands at 43.3, reflecting a relatively high valuation. Despite this, the ROE and ROCE metrics are at 7.79% and 8.92% respectively, indicating room for improvement in efficiency and profitability. With a low OPM of 5%, there is a need for cost management strategies. The company's debt levels are moderate, with borrowings at 369Cr and a comfortable interest coverage ratio of 2.44x. Overall, SPML Infra Ltd shows potential for growth, but operational efficiency and debt management are key areas to focus on for enhanced shareholder value.

Competitors of SPML Infra Ltd – a Multi-sector Infrastructure Player

All Competitor Stocks of SPML Infra Ltd – a Multi-sector Infrastructure Player

Quarterly Result

Last Updated: August 20, 2025, 3:15 am

Below is a detailed analysis of the quarterly data for SPML Infra Ltd - a Multi-sector Infrastructure Player based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 156.00 Cr.. The value appears to be declining and may need further review. It has decreased from 189.00 Cr. (Mar 2025) to 156.00 Cr., marking a decrease of 33.00 Cr..
• For Expenses, as of Jun 2025, the value is 149.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 179.00 Cr. (Mar 2025) to 149.00 Cr., marking a decrease of 30.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 5.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00%.
• For Other Income, as of Jun 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 19.00%. The value appears to be increasing, which may not be favorable. It has increased from 4.00% (Mar 2025) to 19.00%, marking an increase of 15.00%.
• For Net Profit, as of Jun 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.69. The value appears strong and on an upward trend. It has increased from 1.68 (Mar 2025) to 1.69, marking an increase of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:58 pm

Growth

Last Updated: September 5, 2025, 1:36 pm

Balance Sheet

Last Updated: September 10, 2025, 2:33 pm

Below is a detailed analysis of the balance sheet data for SPML Infra Ltd - a Multi-sector Infrastructure Player based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 755.00 Cr.. The value appears strong and on an upward trend. It has increased from 450.00 Cr. (Mar 2024) to 755.00 Cr., marking an increase of 305.00 Cr..
• For Borrowings, as of Mar 2025, the value is 369.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 549.00 Cr. (Mar 2024) to 369.00 Cr., marking a decrease of 180.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 828.00 Cr.. The value appears to be improving (decreasing). It has decreased from 883.00 Cr. (Mar 2024) to 828.00 Cr., marking a decrease of 55.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,967.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,892.00 Cr. (Mar 2024) to 1,967.00 Cr., marking an increase of 75.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Mar 2024) to 6.00 Cr., marking a decrease of 36.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 38.00 Cr. (Mar 2024) to 39.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,922.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,812.00 Cr. (Mar 2024) to 1,922.00 Cr., marking an increase of 110.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,967.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,892.00 Cr. (Mar 2024) to 1,967.00 Cr., marking an increase of 75.00 Cr..

Notably, the Reserves (755.00 Cr.) exceed the Borrowings (369.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for SPML Infra Ltd - a Multi-sector Infrastructure Player, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.61. This value is within the healthy range. It has increased from -1.42 (Mar 24) to 7.61, marking an increase of 9.03.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.36. This value is within the healthy range. It has increased from -1.38 (Mar 24) to 6.36, marking an increase of 7.74.
• For Cash EPS (Rs.), as of Mar 25, the value is 6.35. This value is within the healthy range. It has increased from -0.01 (Mar 24) to 6.35, marking an increase of 6.36.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 101.57. It has increased from 67.46 (Mar 24) to 101.57, marking an increase of 34.11.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 101.57. It has increased from 67.46 (Mar 24) to 101.57, marking an increase of 34.11.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 101.64. It has decreased from 247.46 (Mar 24) to 101.64, marking a decrease of 145.82.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 12.68. This value is within the healthy range. It has increased from 10.56 (Mar 24) to 12.68, marking an increase of 2.12.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.56. This value is within the healthy range. It has increased from 10.12 (Mar 24) to 12.56, marking an increase of 2.44.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.36. This value is within the healthy range. It has increased from -0.19 (Mar 24) to 7.36, marking an increase of 7.55.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.23. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 6.23, marking an increase of 6.68.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.32. This value is within the healthy range. It has increased from -1.31 (Mar 24) to 6.32, marking an increase of 7.63.
• For PBDIT Margin (%), as of Mar 25, the value is 12.47. This value is within the healthy range. It has increased from 4.26 (Mar 24) to 12.47, marking an increase of 8.21.
• For PBIT Margin (%), as of Mar 25, the value is 12.36. This value is within the healthy range. It has increased from 4.08 (Mar 24) to 12.36, marking an increase of 8.28.
• For PBT Margin (%), as of Mar 25, the value is 7.24. This value is below the healthy minimum of 10. It has increased from -0.07 (Mar 24) to 7.24, marking an increase of 7.31.
• For Net Profit Margin (%), as of Mar 25, the value is 6.13. This value is within the healthy range. It has increased from -0.18 (Mar 24) to 6.13, marking an increase of 6.31.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.22. This value is below the healthy minimum of 8. It has increased from -0.52 (Mar 24) to 6.22, marking an increase of 6.74.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.22. This value is below the healthy minimum of 15. It has increased from -1.95 (Mar 24) to 6.22, marking an increase of 8.17.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.89. This value is below the healthy minimum of 10. It has increased from 4.49 (Mar 24) to 6.89, marking an increase of 2.40.
• For Return On Assets (%), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 5. It has increased from -0.36 (Mar 24) to 2.43, marking an increase of 2.79.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has decreased from 0.85 (Mar 24) to 0.43, marking a decrease of 0.42.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has decreased from 1.54 (Mar 24) to 0.47, marking a decrease of 1.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.39. It has decreased from 0.56 (Mar 24) to 0.39, marking a decrease of 0.17.
• For Current Ratio (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has increased from 1.50 (Mar 24) to 1.83, marking an increase of 0.33.
• For Quick Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 1.74, marking an increase of 0.30.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 15.16. This value exceeds the healthy maximum of 8. It has increased from 1.55 (Mar 24) to 15.16, marking an increase of 13.61.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.44. This value is below the healthy minimum of 3. It has increased from 0.98 (Mar 24) to 2.44, marking an increase of 1.46.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 3. It has increased from 0.92 (Mar 24) to 2.20, marking an increase of 1.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,295.17. It has increased from 1,006.59 (Mar 24) to 1,295.17, marking an increase of 288.58.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.77. This value is within the healthy range. It has increased from 0.76 (Mar 24) to 1.77, marking an increase of 1.01.
• For EV / EBITDA (X), as of Mar 25, the value is 14.18. This value is within the healthy range. It has decreased from 17.88 (Mar 24) to 14.18, marking a decrease of 3.70.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 0.52 (Mar 24) to 1.56, marking an increase of 1.04.
• For Price / BV (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has decreased from 1.93 (Mar 24) to 1.56, marking a decrease of 0.37.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 0.52 (Mar 24) to 1.56, marking an increase of 1.04.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.03, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness